New York State Common Retirement Fund decreased its holdings in shares of ChampionX Corporation (NASDAQ:CHX - Free Report) by 78.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 85,625 shares of the company's stock after selling 311,898 shares during the quarter. New York State Common Retirement Fund's holdings in ChampionX were worth $2,552,000 as of its most recent SEC filing.
A number of other hedge funds have also added to or reduced their stakes in CHX. Xponance Inc. boosted its holdings in ChampionX by 6.1% in the 4th quarter. Xponance Inc. now owns 27,389 shares of the company's stock valued at $745,000 after purchasing an additional 1,578 shares during the period. Sei Investments Co. lifted its position in ChampionX by 6.9% during the fourth quarter. Sei Investments Co. now owns 776,535 shares of the company's stock worth $21,114,000 after purchasing an additional 49,885 shares during the period. KLP Kapitalforvaltning AS acquired a new stake in ChampionX during the fourth quarter worth about $1,071,000. Vanguard Group Inc. raised its position in shares of ChampionX by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 19,964,329 shares of the company's stock valued at $542,830,000 after buying an additional 227,627 shares in the last quarter. Finally, Mitsubishi UFJ Trust & Banking Corp lifted its holdings in shares of ChampionX by 17.8% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 100,804 shares of the company's stock worth $2,741,000 after acquiring an additional 15,263 shares during the period. Institutional investors own 98.99% of the company's stock.
Analyst Upgrades and Downgrades
Separately, Stifel Nicolaus boosted their price target on ChampionX from $39.00 to $40.00 and gave the stock a "buy" rating in a report on Monday, May 5th.
Read Our Latest Stock Analysis on CHX
ChampionX Stock Performance
NASDAQ CHX opened at $25.81 on Wednesday. The company has a market capitalization of $4.94 billion, a P/E ratio of 17.09, a P/E/G ratio of 5.04 and a beta of 1.49. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.62 and a current ratio of 2.25. ChampionX Corporation has a 52-week low of $21.92 and a 52-week high of $35.36. The company has a fifty day moving average of $25.58 and a 200-day moving average of $27.04.
ChampionX (NASDAQ:CHX - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.41 by $0.09. The firm had revenue of $864.46 million for the quarter, compared to analysts' expectations of $900.59 million. ChampionX had a return on equity of 19.25% and a net margin of 8.20%. The company's revenue for the quarter was down 6.3% compared to the same quarter last year. During the same period last year, the firm earned $0.50 earnings per share. As a group, equities research analysts predict that ChampionX Corporation will post 1.92 EPS for the current fiscal year.
ChampionX Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 3rd will be given a dividend of $0.095 per share. The ex-dividend date is Thursday, July 3rd. This represents a $0.38 dividend on an annualized basis and a yield of 1.47%. ChampionX's dividend payout ratio (DPR) is currently 25.17%.
ChampionX Profile
(
Free Report)
ChampionX Corporation provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide. The company operates through four segments: Production Chemical Technologies, Production & Automation Technologies, Drilling Technologies, and Reservoir Chemical Technologies.
Read More
Want to see what other hedge funds are holding CHX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ChampionX Corporation (NASDAQ:CHX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider ChampionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ChampionX wasn't on the list.
While ChampionX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.